Among adults treated for community-acquired pneumonia in the outpatient setting, broad-spectrum antibiotics vs macrolide monotherapy were associated with an increased risk for adverse drug events.

An international research team found some beneficial bacteria in people’s guts may not return after broad-spectrum antibiotic exposure, according to a study published in Nature Microbiology. 1.

Vaxcyte’s XpressCF platform enables the development of broad-spectrum vaccines, overcoming the limitations of traditional cell-based approaches. VAX-31 and VAX-24 are Vaxcyte’s key value drivers. They ...

The need to develop antibiotics to combat growing antimicrobial resistance, combined with the difficulty of their discovery and the lack of financial support for their development, is a major ...